Prosight Management’s Gossamer Bio GOSS Stock Holding History

Prosight Management’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-265,000	Closed	-$575K	–	44
2022 Q4	$575K	Buy	+265,000	New	+$2.18M	0.31%	36

Other funds holding GOSS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Prosight Management's GOSS Position: Q1 2023 in Review

Prosight Management sold out of Gossamer Bio (GOSS) in Q1 2023, closing a stake of 265,000 shares — an estimated $575K sold.

Prosight Management first reported a position in GOSS in Q4 2022 and held it in 1 quarter. The position peaked at $575K in Q4 2022. 111 funds tracked by Wall St. Rank hold GOSS as of Q1 2023.

Prosight Management reported no remaining Gossamer Bio position as of Q1 2023 after selling out during the quarter.
Prosight Management sold 265,000 Gossamer Bio shares in Q1 2023, an estimated $575K.
Prosight Management first reported a position in Gossamer Bio in Q4 2022 and held it in 1 quarter.
Prosight Management's Gossamer Bio position peaked at $575K in Q4 2022.
111 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2023.

Based on Prosight Management's 13F filing for Q1 2023, filed 12 May 2023.